CCWM
ESPR icon

Cassaday & Co Wealth Management’s Esperion Therapeutics ESPR Stock Holding History

Cassaday & Co Wealth Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.9K Hold
10,200
– – ﹤0.01% 730
2025
Q4 		$37.7K Sell
10,200
-1,415
-12% -$4.57K ﹤0.01% 351
2025
Q3 		$30.8K Hold
11,615
– – ﹤0.01% 343
2025
Q2 		$11.4K Hold
11,615
– – ﹤0.01% 332
2025
Q1 		$16.7K Hold
11,615
– – ﹤0.01% 317
2024
Q4 		$25.6K Sell
11,615
-1,667
-13% -$3.89K ﹤0.01% 319
2024
Q3 		$21.9K Buy
13,282
+1,667
+14% +$3.37K ﹤0.01% 311
2024
Q2 		$25.8K Hold
11,615
– – ﹤0.01% 290
2024
Q1 		$31.1K Buy
+11,615
New +$28.2K ﹤0.01% 295

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return